{
    "ticker": "GH",
    "name": "Guardant Health, Inc.",
    "description": "Guardant Health, Inc. is a leading precision oncology company focused on transforming cancer care through its proprietary blood tests and data analytics. Founded in 2012, Guardant Health aims to improve patient outcomes by providing oncologists with actionable insights based on genetic information derived from a simple blood draw. The company's flagship product, Guardant360, is a liquid biopsy test that detects genomic alterations in various types of cancer, enabling personalized treatment strategies. This non-invasive approach to cancer diagnostics allows for earlier detection and ongoing monitoring of tumor dynamics, which is crucial for effective management of the disease. Guardant Health also engages in extensive research and development to expand its testing capabilities and develop new products aimed at enhancing cancer care. With a mission to eliminate cancer as a barrier to health, the company collaborates with leading healthcare institutions and contributes to advancing the field of oncology through its innovative technologies and solutions. Guardant Health is committed to making precision oncology accessible to all patients, thereby revolutionizing the way cancer is diagnosed and treated.",
    "industry": [
        "Healthcare",
        "Biotechnology"
    ],
    "headquarters": "Redwood City, California, USA",
    "founded": "2012",
    "website": "https://www.guardanthealth.com",
    "ceo": "Helmy Eltoukhy",
    "social_media": {
        "twitter": "https://twitter.com/guardanthealth",
        "linkedin": "https://www.linkedin.com/company/guardant-health/"
    },
    "investor_relations": "https://investors.guardanthealth.com",
    "key_executives": [
        {
            "name": "Helmy Eltoukhy",
            "position": "CEO"
        },
        {
            "name": "Misha K. Kurgan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Liquid Biopsy Tests",
            "products": [
                "Guardant360",
                "GuardantOMNI"
            ]
        },
        {
            "category": "Data Analytics",
            "products": [
                "Guardant Insights"
            ]
        }
    ],
    "seo": {
        "meta_title": "Guardant Health, Inc. | Precision Oncology Solutions",
        "meta_description": "Explore Guardant Health, Inc., a leader in precision oncology, providing innovative blood tests for cancer detection and monitoring. Discover our mission and products.",
        "keywords": [
            "Guardant Health",
            "Precision Oncology",
            "Liquid Biopsy",
            "Cancer Diagnostics",
            "Genomic Testing",
            "Guardant360"
        ]
    },
    "faq": [
        {
            "question": "What is Guardant Health known for?",
            "answer": "Guardant Health is known for its advanced liquid biopsy tests that provide genomic information for cancer treatment."
        },
        {
            "question": "Who is the CEO of Guardant Health?",
            "answer": "Helmy Eltoukhy is the CEO of Guardant Health, Inc."
        },
        {
            "question": "Where is Guardant Health headquartered?",
            "answer": "Guardant Health is headquartered in Redwood City, California, USA."
        },
        {
            "question": "What are Guardant Health's main products?",
            "answer": "Guardant Health's main products include Guardant360 and GuardantOMNI, which are liquid biopsy tests for cancer."
        },
        {
            "question": "When was Guardant Health founded?",
            "answer": "Guardant Health was founded in 2012."
        }
    ],
    "competitors": [
        "NTRA",
        "EXAS",
        "ILMN",
        "CLDX"
    ],
    "related_stocks": [
        "AMGN",
        "BMY",
        "GILD",
        "ABBV"
    ]
}